---
title: 'When gold standards are not so golden: prevalence bias in randomized trials
  on endoscopic colorectal cancer screening'
date: '2023-08-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37530938/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230802180849&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Randomized trials on the effectiveness of screening endoscopy in reducing
  colorectal cancer (CRC) risk have reported statistically significant, but rather
  modest reduction of CRC risk by the screening offer. However, risk estimates in
  these trials included substantial proportions of prevalent CRC cases which were
  early detected, but could not possibly have been prevented by screening. Thereby,
  a key principle of randomized prevention trials is violated that only "at risk"
  persons who do not ...
disable_comments: true
---
Randomized trials on the effectiveness of screening endoscopy in reducing colorectal cancer (CRC) risk have reported statistically significant, but rather modest reduction of CRC risk by the screening offer. However, risk estimates in these trials included substantial proportions of prevalent CRC cases which were early detected, but could not possibly have been prevented by screening. Thereby, a key principle of randomized prevention trials is violated that only "at risk" persons who do not ...